These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 18873868)

  • 1. A means of increasing the tuberculostatic effect of known chemotherapeutic agents.
    EISEMAN B
    J Exp Med; 1948 Aug; 88(2):189-203. PubMed ID: 18873868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prospects for development of new antituberculous drugs].
    Tomioka H
    Kekkaku; 2002 Aug; 77(8):573-84. PubMed ID: 12235850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological question on the agenda of the XI Conference of the Internation Union against Tuberculosis: Tubercle bacilli and chemotherapeutic agents (antibiotics, etc.); sensitivity, resistance and dependence].
    LINZ R
    Acta Tuberc Belg; 1950 Oct; 41(5):302-9. PubMed ID: 14783012
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of a novel inhibitor of isocitrate lyase as a potent antitubercular agent against both active and non-replicating Mycobacterium tuberculosis.
    Liu Y; Zhou S; Deng Q; Li X; Meng J; Guan Y; Li C; Xiao C
    Tuberculosis (Edinb); 2016 Mar; 97():38-46. PubMed ID: 26980494
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Frontier of mycobacterium research--host vs. mycobacterium].
    Okada M; Shirakawa T
    Kekkaku; 2005 Sep; 80(9):613-29. PubMed ID: 16245793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Recent progress in mycobacteriology].
    Okada M; Kobayashi K
    Kekkaku; 2007 Oct; 82(10):783-99. PubMed ID: 18018602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TUBERCULOSTATIC ACTIVITIES OF CHEMOTHERAPEUTIC AGENTS EVALUATED BY A MEDIUM-REPLACING CULTURE METHOD.
    TSUKUMA S; HIGASHI K; KANDA M; KAWAI M; IWAI K
    Acta Tuberc Jpn; 1964 Sep; 14():39-45. PubMed ID: 14246027
    [No Abstract]   [Full Text] [Related]  

  • 9. [Effect of DNA-tropic substances used jointly with tuberculostatic preparations on the development of drug resistance in Mycobacterium tuberculosis].
    Il'ina TB; Vishnevskiĭ BI
    Probl Tuberk; 1980 May; (5):67-70. PubMed ID: 6770368
    [No Abstract]   [Full Text] [Related]  

  • 10. [Design and study of new agents having antitubercular activity: the original compound perchlosone as a potent agent of etiotropic therapy for tuberculosis].
    Vinogradova TI; Aleksandrova AE; Antonenkova EV; Elokhina VN; Nakhmanovich AS
    Probl Tuberk; 1999; (3):45-7. PubMed ID: 10420769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [BACILLI COUNT--A DIRECTIVE FOR TUBERCULOSTATIC THERAPY].
    SERI I
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1964 Feb; 128():50-62. PubMed ID: 14152182
    [No Abstract]   [Full Text] [Related]  

  • 12. The tubercle bacillus and fundamental chemotherapeutic and antibiotic action.
    CORPER HJ; COHN ML
    Yale J Biol Med; 1946 Oct; 19(1):1-22. PubMed ID: 20275719
    [No Abstract]   [Full Text] [Related]  

  • 13. [CONTRIBUTION TO THE STUDY OF THE MOST EFFECTIVE REGIMEN IN PATIENTS WITH MYCOBACTERIUM TUBERCULOSIS RESISTANT TO THE MAJOR ANTIBACTERIAL DRUGS].
    ASSEEV DD
    Bull Int Union Tuberc; 1964 Sep; 35():156-9. PubMed ID: 14269364
    [No Abstract]   [Full Text] [Related]  

  • 14. [Enzyme activity, antibiotics and tubercle bacillus. II. Effect of pancreatic lipase and streptomycin on the Koch bacillus, on tributyrin and on various tweens].
    PRINA C
    Boll Ist Sieroter Milan; 1953; 32(3-4):124-9. PubMed ID: 13066615
    [No Abstract]   [Full Text] [Related]  

  • 15. [Development of resistance to tuberculostatic drugs by tubercle bacilli under various nutritive culture conditions].
    LEBEK G
    Arzneimittelforschung; 1960 Dec; 10():971-8. PubMed ID: 13760007
    [No Abstract]   [Full Text] [Related]  

  • 16. [Action in vitro of associations of tuberculostatic drugs on strains of mycobacteria with multiple drug resistance].
    Timośca S; Coman G; Petreanu V; Georgescu M; Balteanu E
    Rev Med Chir Soc Med Nat Iasi; 1975; 79(1):49-53. PubMed ID: 806949
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple biological method for determination of small amounts of tuberculostatic agents in fluids.
    Stottmeier KD; Woodley CL; Kubica GP; Beam RE
    Bull World Health Organ; 1967; 37(6):961-6. PubMed ID: 4968791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing the Combined Antibacterial Effect of Isoniazid and Rifampin on Four Mycobacterium tuberculosis Strains Using
    Genestet C; Ader F; Pichat C; Lina G; Dumitrescu O; Goutelle S
    Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29061753
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Tuberculostatic action of viomycin in vitro and in vivo].
    GERNEZ-RIEUX C; TACQUET A; CHENET C
    Ann Inst Pasteur (Paris); 1951 Aug; 81(2):158-63. PubMed ID: 14868864
    [No Abstract]   [Full Text] [Related]  

  • 20. [Further considerations on antituberculosis chemotherapeutic action of p-aminosalicylic hydrazide: in vitro activity on Koch's bacillus resistant to streptomycin and isoniazid].
    CUGURRA F; BALDINI L
    Arch Ital Sci Farmacol; 1959 Oct; 9():529-31. PubMed ID: 13813224
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.